Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Metros Development Co. Ltd. Plans $8 Million IPO for December 13th (MTRS)
Metros Development Co. Ltd. (MTRS) expects to raise $8 million in an initial public offering on Friday, December 13th, IPO...
(TRC.L) (LON:TRC) Insider Sells £6,652.24 in Stock
(TRC.L) (LON:TRC – Get Free Report) insider Danielle Davies sold 665,224 shares of (TRC.L) stock in a transaction dated Thursday,...
Territorial Bancorp (NASDAQ:TBNK) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Territorial Bancorp (NASDAQ:TBNK – Free Report) in a research report sent to investors on...
StockNews.com Initiates Coverage on EnLink Midstream (NYSE:ENLC)
StockNews.com assumed coverage on shares of EnLink Midstream (NYSE:ENLC – Free Report) in a research report released on Friday. The...
Alpine Income Property Trust (NYSE:PINE) vs. Digital Realty Trust (NYSE:DLR) Financial Contrast
Alpine Income Property Trust (NYSE:PINE – Get Free Report) and Digital Realty Trust (NYSE:DLR – Get Free Report) are both...
Permanent Job Losses Rise to 3-Year High in November: Bureau of Labor Statistics
By Andrew Moran New labor market data show that the number of permanent job losses—a measure of workers who lost...